๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of malignant ascites with allogeneic and autologous lymphokine-activated killer cells

โœ Scribed by M Kamada; Y Sakamoto; H Furumoto; K Mori; T Daitoh; M Irahara; T Aono; A Nii; H Yanagawa; S Sone; T Ogura

Book ID
118890058
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
112 KB
Volume
31
Category
Article
ISSN
0020-7292

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Immunotherapy of cancer with lymphokines
Immunotherapy of cancer with lymphokines and lymphokine-activated killer cells
โœ John W. Yarbro ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 996 KB

Our expanding knowledge of the immune system has provided a basis of rationality for immunotherapy . Some non-specific immunotherapy has achieved the status of standard treatment: interferon in hairy cell leukemia and chronic myelogenous leukemia, BCG in bladder cancer, and levamisole in colon cance

Lymphokine-activated killer cell activit
Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors
โœ Roderich E. Schwarz; Shunzaburo Iwatsuki; Ronald B. Herberman; Theresa L. Whites ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 631 KB

Lymphokine-activated killer cells were generated from peripheral blood mononuclear cells of 33 patients with liver tumors (benign, 6; primary malignant, 10; metastatic, 17) and 10 healthy individuals. Although peripheral blood mononuclear cell yield was significantly lower (p < 0.01) in patients wit